CXCR5 and B-cell non-Hodgkin lymphoma: CXCL13, the ligand for CXCR5, is overexpressed in salivary glands of pSS patients, and increased expression of CXCL13 is associated with increased B cell hyperactivity, and development of B cell lymphoma (6, 7, 60).